SkyQuest Technology Group recently introduced Cannabis Testing Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Cannabis Testing Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Global Cannabis Testing Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.87 billion in 2024 to USD 6.52 billion by 2032, growing at a CAGR of 16.9% during the forecast period (2025-2032).
The utilization of cannabis extracts in treating numerous neurological and mental disorders has surged alongside the rise in both the prevalence and production of cannabis. This escalating cannabis testing market trend is expected to fuel substantial growth in the market over the forecast period. According to the European Brain Council, there are approximately 600 reported neurological disorders worldwide, positioning mental disorders among the leading causes of global ill-health and disability.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/cannabis-testing-market
Notably, depression stands out as the most prevalent mental disorder, affecting over 264 million individuals of all ages globally, with a higher incidence among women. This growing prevalence underscores the significance of cannabis testing in evaluating the efficacy and safety of cannabis-based treatments. Additionally, the increasing recognition and adoption of software services within laboratories conducting cannabis testing serve as pivotal factors propelling the cannabis testing industry expansion, enhancing testing capabilities and accuracy in analyzing cannabis-related products.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Cannabis Testing Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Cannabis Testing Market is segmented by Product Type, Testing Type, End-User and region.
Based on Product Type, the market is segmented into Analytical Instruments, Consumables and Software.
Based on Testing Type, the market is segmented into Potency Testing, Pesticide Screening, Heavy Metal Testing, Microbial Analysis, Residual Solvent Testing, Terpene Profiling and Other Cannabis Testing Types.
Based on End-User, the market is segmented into Product & Software End Users (Cannabis Testing Laboratories (Small-scale laboratories, Medium-scale laboratories, Large-scale laboratories), Research Institutions), Services (Cannabis Drug Manufacturers & Dispensaries, Cannabis Cultivators).
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Cannabis Testing Market – Regional Analysis:
In 2022, North America emerged as the powerhouse of the cannabis testing market, commanding an impressive 84.6% revenue share and poised for sustained growth with a significant CAGR projected for the forecast period. A key driving force behind this expansion is the proliferation of testing laboratories, a direct response to stringent governmental regulations governing marijuana cultivation practices in the region.
The Asia Pacific anticipates a remarkable CAGR of 25.9% in the cannabis testing market, indicative of a substantial surge. This growth surge is propelled by the escalating trend of legalizing medical cannabis across multiple countries in the region. As legalization gains momentum, the demand for cannabis testing services is expected to soar, driven by governmental bodies and businesses prioritizing the assurance of safety and efficacy in medical cannabis products. This heightened emphasis on rigorous testing underscores the critical role these services play in ensuring the quality and reliability of medical cannabis offerings.
Top Market Players in Cannabis Testing Market are:
Shimadzu Corporation (Japan)
Merck KGaA (Sigma-Aldrich) (Germany)
Restek Corporation (United States)
PerkinElmer Inc. (United States)
Danaher Corporation (United States)
Thermo Fisher Scientific Inc. (United States)
Waters Corporation (United States)
Sartorius AG (Germany)
Hamilton Company (United States)
Eurofins Scientific (Luxembourg)
SGS SA (Switzerland)
MCS, Inc. (United States)
ProVerde Laboratories (United States)
PharmLabs LLC (United States)
SC Labs (United States)
Sigma Analytical Services (Canada)
Digipath Inc. (United States)
Accelerated Technology Laboratories Inc. (United States)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/cannabis-testing-market
Recent Developments in Cannabis Testing Market:
In February 2024, The Bank of Guam in the United States, has launched Cannabis Banking, a program providing banking services for the cannabis industry on Guam and the Commonwealth of the Northern Mariana Islands. With the launch of Cannabis Banking, the Bank of Guam becomes the first local financial institution in this region to serve all tiers of cannabis-related businesses, or CRBs.
In December 2023, PSI Labs, one of the first licensed marijuana safety labs in Michigan, closed its doors after eight and a half years of testing marijuana for contaminants and potency. Ben Rosman, co-founder and CEO of Ann Arbor’s PSI Labs, said that accuracy proved to be bad for business.
Take Action Now: Secure Your Cannabis Testing Market Today – https://www.skyquestt.com/buy-now/cannabis-testing-market
Forward-Looking Insights
The Cannabis Testing Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
